Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir monotherapy in chronic hepatitis B in routine outpatient practice
2008-003214-94Phase 3Terminated
- Sponsor
- Policlinico di Milano
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Policlinico di Milano. Primary endpoint: HBV DNA suppression at week 48. Started Nov 2008; status: terminated.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2008-003214-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003214-94.